UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

The Journal of clinical investigation, 2011-04, Vol.121 (4), p.1298-1312

2011

Link zum Volltext

Verfügbarkeit prüfen

CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases

Cancer and metastasis reviews, 2006-12, Vol.25 (4), p.611-619

2006

Link zum Volltext

Verfügbarkeit prüfen

GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche

Neoplasia (New York, N.Y.), 2010-02, Vol.12 (2), p.116,IN4-127,IN4

2010

Link zum Volltext

Verfügbarkeit prüfen

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

American Journal of Physiology: Cell Physiology, 2008-09, Vol.295 (3), p.C836-C843

2008

Link zum Volltext

Verfügbarkeit prüfen

Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

Journal of cellular biochemistry, 2008-10, Vol.105 (2), p.370-380

2008

Link zum Volltext

Verfügbarkeit prüfen

CCL2 as an Important Mediator of Prostate Cancer Growth In Vivo through the Regulation of Macrophage Infiltration

Neoplasia (New York, N.Y.), 2007-07, Vol.9 (7), p.556-562

2007

Link zum Volltext

Verfügbarkeit prüfen

CCL2 is a Potent Regulator of Prostate Cancer Cell Migration and Proliferation

Neoplasia (New York, N.Y.), 2006-07, Vol.8 (7), p.578-586

2006

Link zum Volltext

Verfügbarkeit prüfen

Pathogenesis and Treatment of Prostate Cancer Bone Metastases: Targeting the Lethal Phenotype

Journal of clinical oncology, 2005-11, Vol.23 (32), p.8232-8241

2005

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Evaluation of AT-101 (R-(—)-Gossypol Acetic Acid) in Androgen-Independent Growth of VCaP Prostate Cancer Cells in Combination with Surgical Castration

Neoplasia (New York, N.Y.), 2007-12, Vol.9 (12), p.1030-1037

2007

Link zum Volltext

Verfügbarkeit prüfen

An In Vivo Mouse Model for Human Prostate Cancer Metastasis

Neoplasia (New York, N.Y.), 2008-04, Vol.10 (4), p.371,IN4-379,IN4

2008

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

Clinical cancer research, 2019-04, Vol.25 (8), p.2403-2413

2019

Link zum Volltext

Verfügbarkeit prüfen

CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac

Journal of cellular biochemistry, 2008-08, Vol.104 (5), p.1587-1597

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

Cancer research (Chicago, Ill.), 2007-10, Vol.67 (19), p.9417-9424

2007

Link zum Volltext

Verfügbarkeit prüfen

The evolving biology and treatment of prostate cancer

The Journal of clinical investigation, 2007-09, Vol.117 (9), p.2351-2361

2007

Link zum Volltext

Verfügbarkeit prüfen

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma

Cancer, 2017-03, Vol.123 (6), p.1061-1070

2017

Link zum Volltext

Verfügbarkeit prüfen

The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy

CA: a cancer journal for clinicians, 2007-07, Vol.57 (4), p.225-241

2007

Link zum Volltext

Verfügbarkeit prüfen

Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension

The Journal of pharmacology and experimental therapeutics, 2004-06, Vol.309 (3), p.1011

2004

Link zum Volltext

Verfügbarkeit prüfen

GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta

Arteriosclerosis, thrombosis, and vascular biology, 2005-08, Vol.25 (8), p.1596

2005

Link zum Volltext

Verfügbarkeit prüfen

Detection and Isolation of Circulating Tumor Cells in Urologic Cancers: A Review

Neoplasia (New York, N.Y.), 2004-07, Vol.6 (4), p.302-309

2004

Link zum Volltext

Verfügbarkeit prüfen

Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo

Journal of cellular biochemistry, 2008-01, Vol.103 (1), p.1-8

2008

Link zum Volltext

Verfügbarkeit prüfen

PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells

Journal of cellular biochemistry, 2007-08, Vol.101 (5), p.1292-1300

2007

Link zum Volltext

Verfügbarkeit prüfen

PI3-Kinase–Induced Hyperreactivity in DOCA-Salt Hypertension Is Independent of GSK-3 Activity

Hypertension (Dallas, Tex. 1979), 2003-04, Vol.41 (4), p.898-902

2003

Link zum Volltext

Verfügbarkeit prüfen

Can we target the chemokine network for cancer therapeutics?

Current cancer drug targets, 2006-12, Vol.6 (8), p.659

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(64)
Buchkapitel
(1)

Sprache

Englisch
(65)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow

CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases

GAS6/AXL Axis Regulates Prostate Cancer Invasion, Proliferation, and Survival in the Bone Marrow Niche

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

Annexin II/Annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

CCL2 as an Important Mediator of Prostate Cancer Growth In Vivo through the Regulation of Macrophage Infiltration

CCL2 is a Potent Regulator of Prostate Cancer Cell Migration and Proliferation

Pathogenesis and Treatment of Prostate Cancer Bone Metastases: Targeting the Lethal Phenotype

In Vivo Evaluation of AT-101 (R-(—)-Gossypol Acetic Acid) in Androgen-Independent Growth of VCaP Prostate Cancer Cells in Combination with Surgical Castration

An In Vivo Mouse Model for Human Prostate Cancer Metastasis

Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors

CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications

The evolving biology and treatment of prostate cancer

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma

The Lethal Phenotype of Cancer: The Molecular Basis of Death Due to Malignancy

Rho/Rho kinase and phosphoinositide 3-kinase are parallel pathways in the development of spontaneous arterial tone in deoxycorticosterone acetate-salt hypertension

GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta

Detection and Isolation of Circulating Tumor Cells in Urologic Cancers: A Review

Co-inoculation of prostate cancer cells with U937 enhances tumor growth and angiogenesis in vivo

PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells

PI3-Kinase–Induced Hyperreactivity in DOCA-Salt Hypertension Is Independent of GSK-3 Activity

Can we target the chemokine network for cancer therapeutics?

Suchergebnisse filtern